1. Home
  2. COEP vs ALOT Comparison

COEP vs ALOT Comparison

Compare COEP & ALOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • ALOT
  • Stock Information
  • Founded
  • COEP 2017
  • ALOT 1969
  • Country
  • COEP United States
  • ALOT United States
  • Employees
  • COEP N/A
  • ALOT N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • ALOT Computer peripheral equipment
  • Sector
  • COEP Health Care
  • ALOT Technology
  • Exchange
  • COEP Nasdaq
  • ALOT Nasdaq
  • Market Cap
  • COEP 72.1M
  • ALOT 78.2M
  • IPO Year
  • COEP N/A
  • ALOT N/A
  • Fundamental
  • Price
  • COEP $14.79
  • ALOT $9.04
  • Analyst Decision
  • COEP
  • ALOT
  • Analyst Count
  • COEP 0
  • ALOT 0
  • Target Price
  • COEP N/A
  • ALOT N/A
  • AVG Volume (30 Days)
  • COEP 34.6K
  • ALOT 15.3K
  • Earning Date
  • COEP 11-10-2025
  • ALOT 12-11-2025
  • Dividend Yield
  • COEP N/A
  • ALOT N/A
  • EPS Growth
  • COEP N/A
  • ALOT N/A
  • EPS
  • COEP N/A
  • ALOT N/A
  • Revenue
  • COEP $263,555.00
  • ALOT $151,593,000.00
  • Revenue This Year
  • COEP N/A
  • ALOT N/A
  • Revenue Next Year
  • COEP N/A
  • ALOT N/A
  • P/E Ratio
  • COEP N/A
  • ALOT N/A
  • Revenue Growth
  • COEP N/A
  • ALOT 0.63
  • 52 Week Low
  • COEP $2.31
  • ALOT $7.53
  • 52 Week High
  • COEP $19.19
  • ALOT $17.24
  • Technical
  • Relative Strength Index (RSI)
  • COEP 46.31
  • ALOT 37.41
  • Support Level
  • COEP $14.50
  • ALOT $8.68
  • Resistance Level
  • COEP $15.49
  • ALOT $9.23
  • Average True Range (ATR)
  • COEP 0.73
  • ALOT 0.22
  • MACD
  • COEP -0.10
  • ALOT -0.02
  • Stochastic Oscillator
  • COEP 14.91
  • ALOT 30.74

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About ALOT AstroNova Inc.

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Share on Social Networks: